Kiyoshi Nakamura

Title: Kiyoshi Nakamura: Innovator in Pharmaceutical Chemistry

Introduction

Kiyoshi Nakamura is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic applications. His work has garnered attention for its potential impact on health and medicine.

Latest Patents

Kiyoshi Nakamura holds a patent for .omega.-(N-acylamino)alkylphosphoryl ethanolamines. This invention focuses on new .omega.-(N-acylamino)alkylphosphoryl ethanolamines and their pharmaceutically acceptable acid addition salts. These compounds exhibit superior renin-inhibitory activities, antihypertensive activities, and cholesterol-lowering activities. The preparation of these compounds involves specific chemical reactions, including the reaction of an .omega.-(N-acylamino) alkanol with a 2-(N-substituted amino)ethyl phosphate or its derivative.

Career Highlights

Kiyoshi Nakamura is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing pharmaceutical research and development. His innovative approach to drug formulation has contributed to the company's reputation in the industry.

Collaborations

Kiyoshi has collaborated with notable colleagues, including Masanao Shimizu and Kouji Hayashi. Their combined expertise has fostered a productive environment for innovation and research.

Conclusion

Kiyoshi Nakamura's contributions to pharmaceutical chemistry highlight his role as a leading inventor in the field. His patented work on .omega.-(N-acylamino)alkylphosphoryl ethanolamines showcases his commitment to developing effective therapeutic solutions.